Literature DB >> 18519012

Risk factors for benign prostatic hyperplasia.

Steven J Jacobsen1.   

Abstract

This review summarizes recent findings regarding risk factors for benign prostatic hyperplasia (BPH), including new data on hormonal factors, growth factors, comorbid conditions and lifestyle, diet, and exercise as they relate to BPH. In addition, it addresses the design and measurement issues that influence the inference that can be drawn from those studies. Most of the population-based studies on BPH have provided only modest insight into risk factors for BPH. The relationships with circulating levels of steroid hormones and growth factors are still unclear, whereas the association between sexual function and BPH is fairly consistent. Whether this represents a cause and effect relationship or is due to some unobserved confounding factor remains uncertain. There are few data on lifestyle factors that may be amenable to intervention. As future studies aim to address these issues, they should be carried out with rigorous methods, bypassing as many of the methodologic shortcomings of past studies as possible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18519012     DOI: 10.1007/s11934-007-0074-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  27 in total

1.  An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction.

Authors:  J S Green; S T Holden; P Bose; D P George; W G Bowsher
Journal:  Int J Impot Res       Date:  2001-12       Impact factor: 2.896

Review 2.  Benign prostatic hyperplasia: antecedents and natural history.

Authors:  H A Guess
Journal:  Epidemiol Rev       Date:  1992       Impact factor: 6.222

3.  Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake.

Authors:  R Gass
Journal:  BJU Int       Date:  2002-11       Impact factor: 5.588

4.  Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.

Authors:  Aruna V Sarma; Craig A Jaffe; David Schottenfeld; Rodney Dunn; James E Montie; Kathleen A Cooney; John T Wei
Journal:  Urology       Date:  2002-03       Impact factor: 2.649

5.  A brief male sexual function inventory for urology.

Authors:  M P O'Leary; F J Fowler; W R Lenderking; B Barber; P P Sagnier; H A Guess; M J Barry
Journal:  Urology       Date:  1995-11       Impact factor: 2.649

6.  Uses of ecologic analysis in epidemiologic research.

Authors:  H Morgenstern
Journal:  Am J Public Health       Date:  1982-12       Impact factor: 9.308

7.  Diet and benign prostatic hyperplasia: a study in Greece.

Authors:  P Lagiou; J Wuu; A Trichopoulou; C C Hsieh; H O Adami; D Trichopoulos
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

8.  Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

Authors:  J B Meigs; B Mohr; M J Barry; M M Collins; J B McKinlay
Journal:  J Clin Epidemiol       Date:  2001-09       Impact factor: 6.437

9.  Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community.

Authors:  Rosebud O Roberts; Michael M Lieber; Debra J Jacobson; Cynthia J Girman; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2005-06       Impact factor: 7.616

10.  Serum sex hormones and measures of benign prostatic hyperplasia.

Authors:  Rosebud O Roberts; Debra J Jacobson; Thomas Rhodes; George G Klee; Michael M Leiber; Steven J Jacobsen
Journal:  Prostate       Date:  2004-10-01       Impact factor: 4.104

View more
  2 in total

1.  Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.

Authors:  Vladimir Zaichick; Sofia Zaichick
Journal:  Age (Dordr)       Date:  2013-07-14

2.  GOLPH2 expression may serve as diagnostic marker in seminomas.

Authors:  Florian R Fritzsche; Glen Kristiansen; Marc-Oliver Riener; Manfred Dietel; Beibei Oelrich
Journal:  BMC Urol       Date:  2010-02-25       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.